Challenge studies for COVID-19 vaccines are “incomprehensible” as long as there are safer alternatives, Generex CEO Joe Moscato said yesterday, responding to a letter from lawmakers last week on the subject. Read More

A New York healthcare network is studying famotidine, the active ingredient in the heartburn drug Pepcid, as a potential treatment for COVID-19. Read More

Sanofi and Regeneron have modified their clinical trial of the rheumatoid arthritis drug Kevzara (sarilumab) as a COVID-19 treatment after preliminary results found no benefit in one group. Read More

Japan’s Prime Minister Shinzo Abe said that the country may soon approve Gilead’s remdesivir for treatment of COVID-19. Read More

The presence of antibodies in the blood may be one measure used to allow people with COVID-19 go back to work. Read More

The findings will be made available to the global scientific community. Read More

To expand their availability during the pandemic, the FDA has temporarily relaxed its regulations on the use of certain digital pathology devices in laboratories. Read More

Congress last week allocated $25 billion to expand access to COVID-19 diagnostic tests as the FDA continues to pull out all the stops to get tests to the marketplace via Emergency Use Authorizations (EUAs) that exempt devicemakers from liability for product failures. Read More